Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and large intestine.
CITATION STYLE
Andreev, D. N., & Maev, I. V. (2021). Rebamipide: Evidence base for use in gastroenterology. Terapevticheskii Arkhiv, 92(12), 97–104. https://doi.org/10.26442/00403660.2020.12.200455
Mendeley helps you to discover research relevant for your work.